MedPath

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

Not Applicable
Recruiting
Conditions
Traumatic Brain Injury
Registration Number
NCT06520358
Lead Sponsor
University of Florida
Brief Summary

Acute intermittent hypoxia (AIH) involves 1-2min of breathing low oxygen air to stimulate neuroplasticity. Animal and human studies show that AIH improves motor function after neural injury, particularly when paired with task-specific training. Using a double blind cross-over study we will test whether AIH and task-specific airway protection training improves airway protection more than training alone in individuals with chronic mild-moderate traumatic brain injury (TBI).

Detailed Description

Recent studies have found that acute intermittent hypoxia (AIH)-or repetitive exposure to brief episodes of low inspired oxygen--is a promising new strategy that can help restore motor function by promoting neuroplasticity throughout the central nervous system (CNS). Both rodent and human studies show that motor function is further enhanced when AIH is paired with task-specific training/rehabilitation (TST). Therefore, this study will investigate the therapeutic potential of combining AIH with a task-specific airway protection training. We propose that the combined use of AIH + TST will enhance the magnitude and duration of TST training alone in individuals with chronic traumatic brain injury.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Adults aged 21-80 years
  • A mild to moderate traumatic brain injury (TBI) confirmed by medical records
  • A Glasgow Coma Scale score between 9-15
  • Able to consent independently
  • Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study
Exclusion Criteria
  • Other neurological diagnoses or a diagnosis of a severe psychiatric disorder
  • Severe aphasia preventing a participant from understanding the protocol and consent form
  • Pre-existing hypoxic pulmonary disease
  • History of obstructive lung diseases such as chronic obstructive pulmonary disease (COPD) or significant asthma)
  • Severe hypertension (>160/100)
  • History of head and neck cancer
  • Allergy to barium sulfate
  • Ischemic cardiac disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Duration of laryngeal vestibule closure (dLVC)Pre-intervention, 1 day after intervention block and 1-week post intervention

Time in (msec) the laryngeal vestibule stays closed during a swallow

Time to laryngeal vestibule closure (Time-to-LVC)Pre-intervention, 1 day after intervention block and 1-week post intervention

Time in (msec) it takes to close the laryngeal vestibule after swallow initiation

Secondary Outcome Measures
NameTimeMethod
Penetration-Aspiration Scale ScoresPre-intervention, 1 day after intervention block and 1-week post intervention

The penetration-aspiration scale (PAS) will be used to assess penetration or aspiration; the PAS is an 8-point scale that ranges from 1 (no penetration/aspiration) to 8 (aspiration with no cough response).

Trial Locations

Locations (1)

University of Florida

🇺🇸

Jacksonville, Florida, United States

University of Florida
🇺🇸Jacksonville, Florida, United States
Alicia Vose, PhD
Contact
904-244-9440
alicia.vose@jax.ufl.edu
Maribel Ciampitti, MS
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.